The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
<iframe src="https://statesidedaily.com/embed/cluster/0bafbb6d4e87ca20584dae599ad46efc3f77a435" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom"></iframe>
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
